DK2702033T3 - Anvendelse af 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminiumsalte i behandlingen af hjertekarsygdom - Google Patents
Anvendelse af 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminiumsalte i behandlingen af hjertekarsygdom Download PDFInfo
- Publication number
- DK2702033T3 DK2702033T3 DK12720465.9T DK12720465T DK2702033T3 DK 2702033 T3 DK2702033 T3 DK 2702033T3 DK 12720465 T DK12720465 T DK 12720465T DK 2702033 T3 DK2702033 T3 DK 2702033T3
- Authority
- DK
- Denmark
- Prior art keywords
- ethyl
- carboxy
- dimethylpropane
- aminium
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/10—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C225/04—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated
- C07C225/06—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and acyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/04—Formation of amino groups in compounds containing carboxyl groups
- C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
- C07C227/08—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/10—Succinic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/12—Acetic acid esters
- C07C69/14—Acetic acid esters of monohydroxylic compounds
- C07C69/145—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
- C07C69/157—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Claims (9)
1. Salt af 3-carboxy-/v-Rthvi-/v./\/-rlimethvlDrnDan-i -aminium mpd rjen generelle formel hvor RI er -
2. Salt af S-carboxy-ZV-ethyl-A^/V-dimethylpropan-l-aminium ifølge krav 1 som er 3-rarhnyv-/V-pt-hvi-/v A/-rtimethylpropan-l-aminiiim (2f)-3-carboxyakrylat
3. Salt af 3-carboxy-/V-ethyl-/V,/\/,dimethylpropan-l-aminium ifølge krav 1, som er 3-carboxy-/V-ethyl-/V,/V-dimethylpropan-l-aminium 2,6-dioxo-l,2,3,6-
arboxylat
4. Salt af S-carboxy-ZV-ethyl-ty/V-dimethylpropan-l-aminium ifølge krav 1, som er S-carboxy-ZV-ethyl-ZV/ZV-dimethylpropan-l-aminium dihydrogenfosfat H?P04
2
5. Fremgangsmåde til fremstilling af 3-carboxy-/V-ethyl-/V,/V-dimethylpropan-l-aminiumsalt omfattende: a. at tilsætte /V,/V-dimethylethylamin til ethyl 4-bromobutanoat i passende solvent for at opnå 4-ethoxy-/V-ethyl-/V,/V-dimethyl-4-oxo-l-butanaminium bromid; b. at passere 4-ethoxy-/V-ethyl-/V,/V-dimethyl-4-oxo-l-butanaminium bromid igennem ionombytnings-resinsøjle for at opnå 4-[ethyl(dimethyl)ammonio] butanoat; c. at tilsætte syre valgt fra gruppen bestående af fumarsyre, orotsyre og fosforsyre i passende solvent for at opnå det tilsvarende 3-carboxy-/V-ethyl-/V,/V-dimethylpropan-l-aminiumsalt.
5.
Fremgangsmåde ifølge krav 5, hvor i trin a) det passende solvent er acetonitril aller acetone.
7.
S-Carboxy-ZV-ethyl-A/z/V-dimethylpropan-l-aminiumsalt valgt fra gruppen aestående af 3-carboxy-/V-ethyl-/V,/V-dimethylpropan-l-aminium (2£)-3-:arboxyakrylat, 2,6-dioxo-l,2,3,6-tetrahydropyrimidin-4-carboxylat og jihydrogenfosfat til anvendelse som et lægemiddel.
i. 3-carboxy-/V-ethyl-/V//V-dimethylpropan-l-aminiumsalt valgt fra gruppen aestående af 3-carboxy-/V-ethyl-/V,/V-dimethylpropan-l-aminium (2f)-3-:arboxyakrylat, 2,6-dioxo-l,2,3,6-tetrahydropyrimidin-4-carboxylat og jihydrogenfosfat til anvendelse i en fremgangsmåde til behandling af ijertekarsygdomme. J. Forbindelsen til anvendelse ifølge krav 8, hvor hjertekarsygdommen er skæmisk hjertesygdom. LO. Forbindelsen til anvendelse ifølge krav 9, hvor den iskæmiske hjertesygdom ar myokardieinfarkt.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11163871 | 2011-04-27 | ||
EP11163839 | 2011-04-27 | ||
EP11163841 | 2011-04-27 | ||
EP11163872 | 2011-04-27 | ||
EP11163840 | 2011-04-27 | ||
PCT/EP2012/057806 WO2012146736A1 (en) | 2011-04-27 | 2012-04-27 | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2702033T3 true DK2702033T3 (da) | 2016-08-29 |
Family
ID=46062261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK12720465.9T DK2702033T3 (da) | 2011-04-27 | 2012-04-27 | Anvendelse af 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminiumsalte i behandlingen af hjertekarsygdom |
Country Status (25)
Country | Link |
---|---|
US (2) | US20140088125A1 (da) |
EP (1) | EP2702033B1 (da) |
JP (1) | JP5997762B2 (da) |
KR (1) | KR20130138827A (da) |
CN (1) | CN103608326B (da) |
AU (1) | AU2012247467B2 (da) |
BR (1) | BR112013027065B1 (da) |
CA (1) | CA2832693C (da) |
CY (1) | CY1117890T1 (da) |
DK (1) | DK2702033T3 (da) |
EA (1) | EA023547B1 (da) |
ES (1) | ES2585558T3 (da) |
GE (1) | GEP20156373B (da) |
HR (1) | HRP20160998T1 (da) |
HU (1) | HUE030415T2 (da) |
IL (1) | IL228891A (da) |
LT (1) | LT2702033T (da) |
MX (1) | MX351765B (da) |
PE (1) | PE20140777A1 (da) |
PL (1) | PL2702033T3 (da) |
PT (1) | PT2702033T (da) |
RS (1) | RS55092B1 (da) |
SI (1) | SI2702033T1 (da) |
SM (1) | SMT201600416B (da) |
WO (1) | WO2012146736A1 (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO3117B1 (ar) * | 2012-12-20 | 2017-09-20 | Grindeks Jsc | استعمال 3- كربوكسي- ن-إيثيل- ن، ن- ثاني ميثيل بروبان-1– أمينيوم أو ملح منه مقبول صيدلانياً في معالجة تصلب الشرايين |
JO3333B1 (ar) * | 2013-09-26 | 2019-03-13 | Grindeks Jsc | استعمال 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium أو ملح مقبول دوائيا منه للوقاية من السكري وعلاجه |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1103259A (en) * | 1913-04-23 | 1914-07-14 | John J Buckley | Fly-paper holder. |
GB1238868A (da) | 1967-08-08 | 1971-07-14 | ||
SU997646A1 (ru) | 1978-11-27 | 1983-02-23 | Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср | Кормова добавка |
IT1210935B (it) | 1981-09-17 | 1989-09-29 | Inst Orch Sinteza Akademi Nauk | Composizione farmaceutica per il trattamento di malattie cardiovascolari. |
SU1680693A1 (ru) * | 1987-03-25 | 1991-09-30 | Институт Органического Синтеза Ан Латвсср | Этил-3-(2,2-диметил-2-этилгидразиний)пропионат иодистый, про вл ющий антиаритмическую активность |
JP3119430B2 (ja) | 1995-07-25 | 2000-12-18 | 大鵬薬品工業株式会社 | 水酸基ラジカル消去剤 |
LV11728B (en) * | 1995-08-21 | 1997-08-20 | Kalvins Ivars | Pharmaceutical composition |
LV11727B (en) * | 1995-08-21 | 1997-08-20 | Kalvins Ivars | Pharmaceutical composition |
US5973026A (en) | 1998-02-02 | 1999-10-26 | Xerox Corporation | Ink jet inks |
DE19956772A1 (de) * | 1999-11-25 | 2001-06-07 | Basf Ag | Verwendung von y-Butyrobetain Salzen zur Herstellung von Zubereitungen für die menschliche und tierische Ernährung |
UA82540C2 (uk) * | 2003-08-04 | 2008-04-25 | "Джоінт Сток Компані Гріндекс" | Солі мелдонію, спосіб їх одержання і фармацевтична композиція (варіанти) на їх основі |
CA2508094A1 (en) | 2005-05-20 | 2006-11-20 | Vivier Canada Inc. | Composition for accelerating collagen synthesis |
US7863274B2 (en) | 2005-07-29 | 2011-01-04 | Concert Pharmaceuticals Inc. | Deuterium enriched analogues of tadalafil as PDE5 inhibitors |
LV13705B (en) | 2006-11-06 | 2008-07-20 | Ivars Kalvins | Process for producing high purity intermolecular salt of 3-carboxy-n,n,n-trimethyl-propane-1-amine hydroxide |
JP4761265B2 (ja) | 2007-10-17 | 2011-08-31 | 学校法人甲南学園 | 核酸合成を促進する化合物を含む組成物およびその利用、並びに当該化合物の製造方法 |
TWI391131B (zh) * | 2007-12-05 | 2013-04-01 | Grindeks Jsc | 3-(2,2,2-三甲基肼)丙酸鹽的新用途 |
WO2009074498A1 (en) * | 2007-12-12 | 2009-06-18 | Grindeks | Medical use of 3- (2, 2, 2-trimethylhydrazinixm) propionate orotate |
KR20120050437A (ko) * | 2009-06-25 | 2012-05-18 | 테트라, 시아 | 신규한 아세틸살리실산 염들 |
WO2010149654A1 (en) * | 2009-06-25 | 2010-12-29 | Grindeks, A Joint Stock Company | Pharmaceutical composition of gamma-butyrobetaine or a pharmaceutically acceptable salt and meldonium or a pharmaceutically acceptable salt |
LV14345B (lv) * | 2009-10-22 | 2011-07-20 | Grindeks, A/S | 4-[Etil(dimetil)amonija]butanoāts un tā izmantošana kardiovaskulāro slimību ārstēšanai |
-
2012
- 2012-04-27 PE PE2013002405A patent/PE20140777A1/es not_active Application Discontinuation
- 2012-04-27 HU HUE12720465A patent/HUE030415T2/en unknown
- 2012-04-27 LT LTEP12720465.9T patent/LT2702033T/lt unknown
- 2012-04-27 US US14/113,709 patent/US20140088125A1/en not_active Abandoned
- 2012-04-27 ES ES12720465.9T patent/ES2585558T3/es active Active
- 2012-04-27 BR BR112013027065A patent/BR112013027065B1/pt active IP Right Grant
- 2012-04-27 CA CA2832693A patent/CA2832693C/en active Active
- 2012-04-27 PL PL12720465T patent/PL2702033T3/pl unknown
- 2012-04-27 SI SI201230664A patent/SI2702033T1/sl unknown
- 2012-04-27 EP EP12720465.9A patent/EP2702033B1/en active Active
- 2012-04-27 EA EA201301080A patent/EA023547B1/ru unknown
- 2012-04-27 PT PT127204659T patent/PT2702033T/pt unknown
- 2012-04-27 AU AU2012247467A patent/AU2012247467B2/en active Active
- 2012-04-27 CN CN201280020494.9A patent/CN103608326B/zh active Active
- 2012-04-27 WO PCT/EP2012/057806 patent/WO2012146736A1/en active Application Filing
- 2012-04-27 RS RS20160684A patent/RS55092B1/sr unknown
- 2012-04-27 JP JP2014506893A patent/JP5997762B2/ja active Active
- 2012-04-27 DK DK12720465.9T patent/DK2702033T3/da active
- 2012-04-27 MX MX2013012551A patent/MX351765B/es active IP Right Grant
- 2012-04-27 KR KR1020137027933A patent/KR20130138827A/ko not_active Application Discontinuation
- 2012-04-27 GE GEAP201213252A patent/GEP20156373B/en unknown
-
2013
- 2013-10-15 IL IL228891A patent/IL228891A/en active IP Right Grant
-
2016
- 2016-08-09 HR HRP20160998TT patent/HRP20160998T1/hr unknown
- 2016-08-09 CY CY20161100780T patent/CY1117890T1/el unknown
- 2016-11-16 SM SM201600416T patent/SMT201600416B/it unknown
-
2017
- 2017-12-01 US US15/828,660 patent/US10351534B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9573882B2 (en) | Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease | |
EP1667960B1 (en) | Meldonium salts, method of their preparation and pharmaceutical composition on their basis | |
US10351534B2 (en) | Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease | |
ZA200600617B (en) | Meldonium salts, method of their preparation and pharmaceutical composition on their basis | |
US8940793B2 (en) | 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease | |
NZ616467B2 (en) | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease | |
ITRM970184A1 (it) | Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine | |
CZ284755B6 (cs) | Acetylsalicyloyl-L-karnitin a způsob jeho výroby |